Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C14H14N2O4S |
| Molecular Weight | 306.337 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=CC=C(C=C1)S(=O)(=O)C2=CC=C(NCC(O)=O)C=C2
InChI
InChIKey=FKKUMFTYSTZUJG-UHFFFAOYSA-N
InChI=1S/C14H14N2O4S/c15-10-1-5-12(6-2-10)21(19,20)13-7-3-11(4-8-13)16-9-14(17)18/h1-8,16H,9,15H2,(H,17,18)
| Molecular Formula | C14H14N2O4S |
| Molecular Weight | 306.337 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Column and thin-layer chromatographic methods for the simultaneous determination of acediasulfone in the presence of cinchocaine, and cefuroxime in the presence of its hydrolytic degradation products. | 2007-05-04 |
|
| Folate-synthesizing enzyme system as target for development of inhibitors and inhibitor combinations against Candida albicans-synthesis and biological activity of new 2,4-diaminopyrimidines and 4'-substituted 4-aminodiphenyl sulfones. | 2004-01-01 |
|
| Evaluation of the sulfones and streptomycin in experimental tuberculosis. | 1949-12-14 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:23:11 GMT 2025
by
admin
on
Mon Mar 31 18:23:11 GMT 2025
|
| Record UNII |
30YP2YHH8W
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C849
Created by
admin on Mon Mar 31 18:23:11 GMT 2025 , Edited by admin on Mon Mar 31 18:23:11 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
ACEDIASULFONE
Created by
admin on Mon Mar 31 18:23:11 GMT 2025 , Edited by admin on Mon Mar 31 18:23:11 GMT 2025
|
PRIMARY | |||
|
DB08926
Created by
admin on Mon Mar 31 18:23:11 GMT 2025 , Edited by admin on Mon Mar 31 18:23:11 GMT 2025
|
PRIMARY | |||
|
C77129
Created by
admin on Mon Mar 31 18:23:11 GMT 2025 , Edited by admin on Mon Mar 31 18:23:11 GMT 2025
|
PRIMARY | |||
|
SUB00242MIG
Created by
admin on Mon Mar 31 18:23:11 GMT 2025 , Edited by admin on Mon Mar 31 18:23:11 GMT 2025
|
PRIMARY | |||
|
30YP2YHH8W
Created by
admin on Mon Mar 31 18:23:11 GMT 2025 , Edited by admin on Mon Mar 31 18:23:11 GMT 2025
|
PRIMARY | |||
|
m1294
Created by
admin on Mon Mar 31 18:23:11 GMT 2025 , Edited by admin on Mon Mar 31 18:23:11 GMT 2025
|
PRIMARY | Merck Index | ||
|
80-03-5
Created by
admin on Mon Mar 31 18:23:11 GMT 2025 , Edited by admin on Mon Mar 31 18:23:11 GMT 2025
|
PRIMARY | |||
|
100000078805
Created by
admin on Mon Mar 31 18:23:11 GMT 2025 , Edited by admin on Mon Mar 31 18:23:11 GMT 2025
|
PRIMARY | |||
|
66451
Created by
admin on Mon Mar 31 18:23:11 GMT 2025 , Edited by admin on Mon Mar 31 18:23:11 GMT 2025
|
PRIMARY | |||
|
201-243-7
Created by
admin on Mon Mar 31 18:23:11 GMT 2025 , Edited by admin on Mon Mar 31 18:23:11 GMT 2025
|
PRIMARY | |||
|
44
Created by
admin on Mon Mar 31 18:23:11 GMT 2025 , Edited by admin on Mon Mar 31 18:23:11 GMT 2025
|
PRIMARY | |||
|
C521214
Created by
admin on Mon Mar 31 18:23:11 GMT 2025 , Edited by admin on Mon Mar 31 18:23:11 GMT 2025
|
PRIMARY | |||
|
DTXSID00229991
Created by
admin on Mon Mar 31 18:23:11 GMT 2025 , Edited by admin on Mon Mar 31 18:23:11 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |